{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"severe-phosphoribosylpyrophosphate-synthetase-superactivity","columns":[{"gene":"","key":"population-3451451f74775026bd0c","label":"Severe phosphoribosylpyrophosphate synthetase superactivity","mondoId":"MONDO:0018464","onsetQualifier":null,"originColumnKey":"MONDO:0018464/ORPHA:411543","originalViews":[{"key":"MONDO:0018464/ORPHA:411543","label":"Severe phosphoribosylpyrophosphate synthetase superactivity","scopeLabel":"ORPHA:411543","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["070bf5c2b684e9ea253fd1b03dac7ea72a624592a713a266cb3a418951c68aaa","0751944da17331b0527771478ae47e79a62d5a88298fc39d5468ba492434c460","12ec75f5a8d57c02e80ded9c2e81bbab3c50d613ea8fd99c7f2e0818aa3ac090","214c0e0271b672a26088602d5267e8cc7beecf1a21141c4d154f98084fc1cf71","3b4f8c4bc7d8afdbdd41fcef664324c72d0d4c6b05f52eeb4de1206296788bdd","4f2b88c7a133dec2d530dc81ad46cb1ce836b438fd2637f7e44d16eb065b47dc","5b8c2a0b9727022ab8a659965c8b40c31105b1fde555cb116e51deea1181896f","6b6207731a5a6d4dcdbd9df5d0b69c32b9e4f7b367e60e003f1cc0414e14e1d2","7c5190df756d84cf2b22aedb4279c6451fd553ace3855d3b37e0d94a09485251","8769bd505585db274cafed2c1b9d570d91a929efbed7ae86d2cbac2aa98261a1","94baf5d6d3386b030026723a8d99123503821024eb03633a0dda8f173b7a9691","a31f85647d02a81c4c935ac6765c9d40fb3950658986cc022c03a6fb8ed8ca15","acb7bee48e769ed2409a2ae80a90cea8138a3990e4d26f0d33d749a5e2e96086","b1161e464bea2f12a16d72e1572a5cf905d4bd7b0d92b916934da1095c712df6","b1b802813cb781ed8af0e4642a22ac633ec7cc74b4b69bd543cdebb22a8d28e5","bb93cded50dfc39334d7067c0be0f59bbc4000b2647f719d645bfcaac653933a","bc283c8e9e2901d3fdb20290cd4234241b5be2f38cea2477b204db5d72087e0c","f50861a9dbb305f6829515d6cddd0e6984adcc6e2308625ddc09e327cc54f73b","f798d9fe2761689ea37f33a2539c1799cb92ed09f992a60625855475014dad1a","fc457d2c650d2ecd461c758a8644263192c61be0953ea0573453e03a90566c4a","fe728850a50b7120d7341bda0658a27589f5296f41c1c40bb8ade0e0ccd6f1c4"],"recordQualifiers":{},"scopeLabel":"ORPHA:411543","sourceIds":["ORPHA:411543"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-3451451f74775026bd0c"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0000707","HP:0001919","HP:0001369","HP:0001251","HP:0020074","HP:0000501","HP:0001263"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":21,"sourceGroups":{"orphanet":21}},"features":[{"hpoId":"HP:0000707","label":"Abnormality of the nervous system","primary":true},{"hpoId":"HP:0001919","label":"Acute kidney injury","primary":true},{"hpoId":"HP:0001369","label":"Arthritis","primary":true},{"hpoId":"HP:0001251","label":"Ataxia","primary":true},{"hpoId":"HP:0020074","label":"Crystalluria","primary":true},{"hpoId":"HP:0000501","label":"Glaucoma","primary":true},{"hpoId":"HP:0001263","label":"Global developmental delay","primary":true},{"hpoId":"HP:0001997","label":"Gout","primary":false},{"hpoId":"HP:0002149","label":"Hyperuricemia","primary":false},{"hpoId":"HP:0003149","label":"Hyperuricosuria","primary":false},{"hpoId":"HP:0001252","label":"Hypotonia","primary":false},{"hpoId":"HP:0003240","label":"Increased phosphoribosylpyrophosphate synthetase level","primary":false},{"hpoId":"HP:0001249","label":"Intellectual disability","primary":false},{"hpoId":"HP:0007178","label":"Motor polyneuropathy","primary":false},{"hpoId":"HP:0000545","label":"Myopia","primary":false},{"hpoId":"HP:0012759","label":"Neurodevelopmental abnormality","primary":false},{"hpoId":"HP:0009830","label":"Peripheral neuropathy","primary":false},{"hpoId":"HP:0002205","label":"Recurrent respiratory infections","primary":false},{"hpoId":"HP:0000083","label":"Renal insufficiency","primary":false},{"hpoId":"HP:0000407","label":"Sensorineural hearing impairment","primary":false},{"hpoId":"HP:0000791","label":"Uric acid nephrolithiasis","primary":false}],"ledeHtml":"Severe phosphoribosylpyrophosphate (PRPP) synthetase superactivity is the severe and early-onset form of PRPP synthetase superactivity, an X-linked disorder of purine metabolism associated with hyperuricemia and hyperuricosuria, that is characterized by urolithiasis, gout and neurodevelopmental anomalies.","mondoId":"MONDO:0018464","node":{"canonicalSlug":"severe-phosphoribosylpyrophosphate-synthetase-superactivity","comparisons":[{"documentSha256":"f9d6d13752964acdd86bf87920ef80307f8fe296bea726989345e46023dad362","key":"legacy-phosphoribosylpyrophosphate-synthetase-superactivity","kind":"legacy","label":"phosphoribosylpyrophosphate synthetase superactivity","memberIds":["MONDO:0010395","MONDO:0018463","MONDO:0018464"],"mondoId":"MONDO:0010395","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/phosphoribosylpyrophosphate-synthetase-superactivity.f9d6d13752964acdd86bf87920ef80307f8fe296bea726989345e46023dad362.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","matchMethod":"same-ontology-node","name":"severe phosphoribosylpyrophosphate synthetase superactivity","paragraphs":["Severe phosphoribosylpyrophosphate (PRPP) synthetase superactivity is the severe and early-onset form of PRPP synthetase superactivity, an X-linked disorder of purine metabolism associated with hyperuricemia and hyperuricosuria, that is characterized by urolithiasis, gout and neurodevelopmental anomalies."],"scope":"exact","source":"MONDO","upstream":"Orphanet:411543","url":"https://monarchinitiative.org/MONDO:0018464"},"ownColumnKeys":["population-3451451f74775026bd0c"],"publication":"published","relationships":[{"kind":"parent","label":"phosphoribosylpyrophosphate synthetase superactivity","mondoId":"MONDO:0010395","slug":"phosphoribosylpyrophosphate-synthetase-superactivity"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[{"reason":"Public source record is not available in the frozen inputs","source":"GARD","url":"https://rarediseases.info.nih.gov/diseases/17682"}],"translation":"pending"},"records":[{"frequencyKind":"range","key":"070bf5c2b684e9ea253fd1b03dac7ea72a624592a713a266cb3a418951c68aaa","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:411543","disease_name":"Severe phosphoribosylpyrophosphate synthetase superactivity","evidence":"TAS","frequency_raw":"HP:0040284","hpo_id":"HP:0001263","is_excluded":false,"label":"Global developmental delay","onset_id":null,"reference":"ORPHA:411543","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"0751944da17331b0527771478ae47e79a62d5a88298fc39d5468ba492434c460","raw":{"aspect":"P","body_system":"ear","disease_id":"ORPHA:411543","disease_name":"Severe phosphoribosylpyrophosphate synthetase superactivity","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000407","is_excluded":false,"label":"Sensorineural hearing impairment","onset_id":null,"reference":"ORPHA:411543","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"12ec75f5a8d57c02e80ded9c2e81bbab3c50d613ea8fd99c7f2e0818aa3ac090","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:411543","disease_name":"Severe phosphoribosylpyrophosphate synthetase superactivity","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0012759","is_excluded":false,"label":"Neurodevelopmental abnormality","onset_id":null,"reference":"ORPHA:411543","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"214c0e0271b672a26088602d5267e8cc7beecf1a21141c4d154f98084fc1cf71","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:411543","disease_name":"Severe phosphoribosylpyrophosphate synthetase superactivity","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001252","is_excluded":false,"label":"Hypotonia","onset_id":null,"reference":"ORPHA:411543","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"3b4f8c4bc7d8afdbdd41fcef664324c72d0d4c6b05f52eeb4de1206296788bdd","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:411543","disease_name":"Severe phosphoribosylpyrophosphate synthetase superactivity","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000707","is_excluded":false,"label":"Abnormality of the nervous system","onset_id":null,"reference":"ORPHA:411543","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"4f2b88c7a133dec2d530dc81ad46cb1ce836b438fd2637f7e44d16eb065b47dc","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:411543","disease_name":"Severe phosphoribosylpyrophosphate synthetase superactivity","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001369","is_excluded":false,"label":"Arthritis","onset_id":null,"reference":"ORPHA:411543","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"5b8c2a0b9727022ab8a659965c8b40c31105b1fde555cb116e51deea1181896f","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:411543","disease_name":"Severe phosphoribosylpyrophosphate synthetase superactivity","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0009830","is_excluded":false,"label":"Peripheral neuropathy","onset_id":null,"reference":"ORPHA:411543","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"6b6207731a5a6d4dcdbd9df5d0b69c32b9e4f7b367e60e003f1cc0414e14e1d2","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:411543","disease_name":"Severe phosphoribosylpyrophosphate synthetase superactivity","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0002149","is_excluded":false,"label":"Hyperuricemia","onset_id":null,"reference":"ORPHA:411543","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"7c5190df756d84cf2b22aedb4279c6451fd553ace3855d3b37e0d94a09485251","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:411543","disease_name":"Severe phosphoribosylpyrophosphate synthetase superactivity","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001919","is_excluded":false,"label":"Acute kidney injury","onset_id":null,"reference":"ORPHA:411543","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"8769bd505585db274cafed2c1b9d570d91a929efbed7ae86d2cbac2aa98261a1","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:411543","disease_name":"Severe phosphoribosylpyrophosphate synthetase superactivity","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001997","is_excluded":false,"label":"Gout","onset_id":null,"reference":"ORPHA:411543","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"94baf5d6d3386b030026723a8d99123503821024eb03633a0dda8f173b7a9691","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:411543","disease_name":"Severe phosphoribosylpyrophosphate synthetase superactivity","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0007178","is_excluded":false,"label":"Motor polyneuropathy","onset_id":null,"reference":"ORPHA:411543","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"a31f85647d02a81c4c935ac6765c9d40fb3950658986cc022c03a6fb8ed8ca15","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:411543","disease_name":"Severe phosphoribosylpyrophosphate synthetase superactivity","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0003240","is_excluded":false,"label":"Increased phosphoribosylpyrophosphate synthetase level","onset_id":null,"reference":"ORPHA:411543","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"acb7bee48e769ed2409a2ae80a90cea8138a3990e4d26f0d33d749a5e2e96086","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:411543","disease_name":"Severe phosphoribosylpyrophosphate synthetase superactivity","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000791","is_excluded":false,"label":"Uric acid nephrolithiasis","onset_id":null,"reference":"ORPHA:411543","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"b1161e464bea2f12a16d72e1572a5cf905d4bd7b0d92b916934da1095c712df6","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:411543","disease_name":"Severe phosphoribosylpyrophosphate synthetase superactivity","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0020074","is_excluded":false,"label":"Crystalluria","onset_id":null,"reference":"ORPHA:411543","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"b1b802813cb781ed8af0e4642a22ac633ec7cc74b4b69bd543cdebb22a8d28e5","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:411543","disease_name":"Severe phosphoribosylpyrophosphate synthetase superactivity","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000083","is_excluded":false,"label":"Renal insufficiency","onset_id":null,"reference":"ORPHA:411543","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"bb93cded50dfc39334d7067c0be0f59bbc4000b2647f719d645bfcaac653933a","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:411543","disease_name":"Severe phosphoribosylpyrophosphate synthetase superactivity","evidence":"TAS","frequency_raw":"HP:0040284","hpo_id":"HP:0000501","is_excluded":false,"label":"Glaucoma","onset_id":null,"reference":"ORPHA:411543","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"bc283c8e9e2901d3fdb20290cd4234241b5be2f38cea2477b204db5d72087e0c","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:411543","disease_name":"Severe phosphoribosylpyrophosphate synthetase superactivity","evidence":"TAS","frequency_raw":"HP:0040284","hpo_id":"HP:0000545","is_excluded":false,"label":"Myopia","onset_id":null,"reference":"ORPHA:411543","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"f50861a9dbb305f6829515d6cddd0e6984adcc6e2308625ddc09e327cc54f73b","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:411543","disease_name":"Severe phosphoribosylpyrophosphate synthetase superactivity","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0003149","is_excluded":false,"label":"Hyperuricosuria","onset_id":null,"reference":"ORPHA:411543","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"f798d9fe2761689ea37f33a2539c1799cb92ed09f992a60625855475014dad1a","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:411543","disease_name":"Severe phosphoribosylpyrophosphate synthetase superactivity","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001251","is_excluded":false,"label":"Ataxia","onset_id":null,"reference":"ORPHA:411543","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"fc457d2c650d2ecd461c758a8644263192c61be0953ea0573453e03a90566c4a","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:411543","disease_name":"Severe phosphoribosylpyrophosphate synthetase superactivity","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001249","is_excluded":false,"label":"Intellectual disability","onset_id":null,"reference":"ORPHA:411543","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"fe728850a50b7120d7341bda0658a27589f5296f41c1c40bb8ade0e0ccd6f1c4","raw":{"aspect":"P","body_system":"respiratory","disease_id":"ORPHA:411543","disease_name":"Severe phosphoribosylpyrophosphate synthetase superactivity","evidence":"TAS","frequency_raw":"HP:0040284","hpo_id":"HP:0002205","is_excluded":false,"label":"Recurrent respiratory infections","onset_id":null,"reference":"ORPHA:411543","source_release":"2026-06-23"},"sourceGroups":["orphanet"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0018464\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>same-ontology-node</dd><dt>Upstream attribution</dt><dd>Orphanet:411543</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>Severe phosphoribosylpyrophosphate (PRPP) synthetase superactivity is the severe and early-onset form of PRPP synthetase superactivity, an X-linked disorder of purine metabolism associated with hyperuricemia and hyperuricosuria, that is characterized by urolithiasis, gout and neurodevelopmental anomalies.</p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0018464\" rel=\"noreferrer\">MONDO</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"severe-phosphoribosylpyrophosphate-synthetase-superactivity","sourceDocuments":[{"name":"MONDO: severe phosphoribosylpyrophosphate synthetase superactivity","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0018464"}],"sourceNote":"","synonyms":["severe PRPP synthetase superactivity","severe PRPS1 superactivity"],"takeawayHtml":"","title":"severe phosphoribosylpyrophosphate synthetase superactivity"},"schemaVersion":1}
